Please select the market sector you are interested in.
Please select the university you are interested in.
Show only Easy Access opportunities.
Narrow your search with a few keywords.
Sign up to our technology alerts and be the first to hear about any new technology opportunities from Scotland's universities
Certain types of university intellectual property can sometimes prove difficult to commercialise through traditional routes, usually because it is at an early stage of development, or because it presents enough uncertainty for companies to risk an investment.
University Technology’s Easy Access portal offers access to this type of intellectual property at no cost, to enable companies to evaluate it and put it to use quickly, with reduced risk.
Easy Access uses quick and simple licence agreements to fast-track the transfer of knowledge and expertise from Scotland’s universities to industry, so that these technologies may be developed for the benefit of the economy and society.
Through this initiative, our aim is to make it easier for Scottish universities and industry to work together and build strong, long-term relationships with industry partners.
Showing 21 - 30 of 86 opportunities
Researchers at the University of Glasgow and the University of the West of Scotland have created a new mechanical bioreactor for the promotion of osteogenesis in stem cells, which is far more reliable and simpler to use than rotary, perfusion or other mechanical bioreactors.
Researchers from the Universities of Edinburgh and Dundee have developed a protein-based surfactant, capable of forming very stable interfaces in aqueous emulsions, with multiple uses in home and personal care formulation.
Researchers at the University of Dundee have discovered that aldosterone antagonists, established drugs for the treatment of cardiovascular and liver disease, have shown significant potential in the treatment and prevention of specific cancers.
Researchers at the University of Dundee have established
a novel transgenic mouse model suitable for the preclinical discovery of compounds for filaggrin-based disorders.
Researchers at the University of Dundee have developed a novel “intelligent” RFA device for destroying solid tumours in situ. This new concept in RFA treatment overcomes the limitations of current technology by providing a safe, versatile and highly effective method for complete tumour ablation ther...
Allopurinol, an established drug for the treatment of gout, has shown significant potential in the effective treatment of chronic stable angina by clinicians
at the University of Dundee.
Researchers at the University of Dundee have identified a sensitive biomarker for vascular endothelial function that could be used as a predictive test for atherosclerosis, or to effectively monitor treatment of the condition.
Currently, licensed HPV vaccines, Cervarix and Gardasil, have been successful in preventing HPV infection and cervical cancers in teenage girls in the UK and other developed countries. However, their high costs have hindered their wider use in preventing other HPV-caused cancers (head and neck, and ...
Applying a host-targeted approach to prevent respiratory infection and disease has merits over pathogen-targeted strategies where evolving drug resistance and vaccine efficacy can be an issue.
mCBMs are engineered multivalent proteins based on the sialic acid (SA)-recognising carbohydrate-binding module (CBM40) derived from bacterial sialidases. Engineered mCBMs have potential as biological agents in respiratory disease by masking cell surface sialic acid receptors.